Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC entered into a definitive agreement to acquire Renal Business from Cantel Medical LLC for approximately $200 million on December 20, 2021. As per the terms, purchase price $196.3 million include a $12.3 million earn out. Upon closing the transaction, the business will be part of Evoqua's Integrated Solutions and Services segment. The purchase price will be funded through a combination of cash and proceeds from the revolving credit facility. The transaction is subject to regulatory approval. The transaction is anticipated to close during Evoqua's second quarter of fiscal 2022, which ends March 31, 2022. As of December 20, 2021, transaction is expected to close in the first quarter of calendar year 2022. BMO Capital Markets Corp. acted as a financial advisor to Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC. Eric Kline, Mateusz Saykiewicz, Barbara Sicalides, Stefanie Brennan, Mamta Shah, Alyson Pirio, Joe Helmsen, Judy O'Grady, Gregory Narsh of Troutman Pepper Hamilton Sanders LLP acted as a legal advisors to Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC.

Evoqua Water Technologies Ltd and Evoqua Water Technologies LLC completed the acquisition of Renal Business from Cantel Medical LLC on January 3, 2022. James Dougherty and Brian Grady of Jones day acted as a legal advisor to STERIS plc.